Navigation Links
Stonegate Report About Unigene Laboratories Inc.
Date:3/13/2008

at nearly double the growth rate for APIs overall.

Unigene has spent the last 20 years focusing on research, manufacturing and delivery technologies for peptides used for medical purposes. That unwavering focus has uniquely positioned Unigene as the only biopharma company that manufactures peptides by recombinant techniques, while also having oral and nasal delivery systems to successfully administer the peptides.

Top-tier partnerships and a portfolio of patents validate UGNE's technology platforms - Both of Unigene's technology platforms can be applied to products addressing a large variety of diseases. The Company has been awarded multiple patents to validate its technologies. Further validation for Unigene's products and technologies comes from partnerships with some top-tier names in the pharmaceutical industry. Partnerships are in place with Upsher- Smith Laboratories, Novartis Pharma AG, and GlaxoSmithKline, and collaborations are in place with world-renowned universities including University of London and Yale University Medical School.

Fortical(R), UGNE's first U.S. product, is in near-dominant position of its market - Fortical(R), Unigene's nasal calcitonin product that was launched in 2005 with partner Upsher-Smith, has exhibited substantial growth, and it currently holds 49% of the nasal sCT market estimated to be in the $200 million range. Because the market leader, Miacalcin(R) (Novartis), is approximately 50% more expensive and contains a nasal irritant (benzalkonium chloride) that is absent from Unigene's product, and because there appears to be no other near-term competitors, Fortical(R) is well positioned to continue growing sales and garnering market share to become the leader in this market.

New indication could catapult calcitonin sales to blockbuster status - Novartis is conducting a Phase III trial investigating the effectiveness of oral calcitonin on osteoarthritis (OA), a painful disease of the joints. Conventional
'/>"/>

SOURCE Unigene Laboratories Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
2. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
3. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
4. Helix BioPharma reports Q2 2008 highlights, financial results
5. Oncothyreon reports full year and fourth quarter 2007 financial results
6. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
7. Alfacell Reports Financial Results for Second Quarter of Fiscal 2008
8. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 13
9. ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
10. Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007
11. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Biotech Leaders to Develop Blueprint to Preserve ... Boosting Rhode Island,s Growing Biotech and Medical ... 14 Several of Rhode Island,s ... biotechnology gathered today at Brown University,s Medical ... medical innovation in Rhode Island and throughout ...
(Date:12/14/2009)... Mass., Dec. 14 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that, owing ... atrial fibrillation drug market will increase more than ... billion in 2018 in the United States, France, ... ,, The new Pharmacor report entitled Atrial ...
(Date:12/11/2009)... Therapeutics, Inc., a biopharmaceutical company focused on improving ... cardiovascular and muscle disease, today announced the publication ... crucial role in the progression of amyotrophic lateral ... neuromuscular synaptic regeneration in mice. The findings, ... journal Science , reveal miR-206 as a ...
(Date:12/11/2009)... Dec. 11 Marrone Bio Innovations (MBI) ... management team. Mr. Chris Hildreth joined MBI as ... responsible for expanding all commercial aspects of the ... Dr. Kin Sing (Ray) Lam joined MBI as ... company,s development efforts in scaling its broad pipeline ...
Breaking Biology Technology:Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3
... U.S. Food and Drug,Administration (FDA) Advisory Committee ... the approval of tolvaptan, Otsuka Pharmaceutical,Development & ... hyponatremia., "Otsuka is pleased that the ... tolvaptan, an investigational selective,V2-vasopressin receptor antagonist," said ...
... MONTREAL, June 25 /PRNewswire-FirstCall/ - ProMetic Life ... has further confirmed the,efficacy of the prion ... Technologies Inc. ("PRDT"), in the removal of ... containing high,concentrations of specific proteins such as ...
... Md., June 25 Martek Biosciences,(Nasdaq: MATK ... of DHA-omega 3 essential for infant brain and ... in the new Pregnium prenatal,supplement from Walmark. Featuring ... at major retailers in the Czech Republic, Slovakia,and ...
Other Biology Technology:U.S. Food and Drug Administration Advisory Committee Recommends Approval of Tolvaptan, an Investigational Treatment for Hyponatremia 2ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference 2ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference 3Eastern European Supplement Leader Walmark Launches Prenatal Product Featuring Martek's life'sDHA(TM) 2Eastern European Supplement Leader Walmark Launches Prenatal Product Featuring Martek's life'sDHA(TM) 3
(Date:12/14/2009)... spending the holidays with big Uncle Frank or bossy ... off with another family, spare a thought for the ... McMaster University and the University of New South Wales ... in groups, members make strategic decisions about their living ... issue of Biology Letters . , The helper ...
(Date:12/14/2009)... defining feature of humans. That,s until examples of tool use ... array of other mammals. Now, a report in the December ... publication, adds an octopus to the growing list of tool ... trick that the researchers call stilt walking. In it, the ... makes its eight arms rigid, and raises the whole assembly ...
(Date:12/14/2009)... MODA Technology Partners, a global software company that ... for the Pharmaceutical industry, today announced the general ... mobile data acquisition platform. The latest release enables ... regulated manufacturing processes. ,, MODA 3.0 includes ... Test Methods: Each test method in the ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Childrens Medical Center 13522 1Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Childrens Medical Center 13522 2Stressed Out College Students Losing Sleep 54301 1Stressed Out College Students Losing Sleep 54301 2Medical Development Group Partners with e Zassi com 28TM 29 to Provide Members Access to Exciting New Software Tool 54298 1Medical Development Group Partners with e Zassi com 28TM 29 to Provide Members Access to Exciting New Software Tool 54298 2Medical Development Group Partners with e Zassi com 28TM 29 to Provide Members Access to Exciting New Software Tool 54298 3
... A new technology with research and clinical application ... invented and developed by University of Queensland researchers. ... Institute for Bioengineering & Nanotechnology, has developed fluorescent ... than current detection methods. , The research ...
... WASHINGTON DC On Thursday, 22 May 2008, the ... TM, an exciting, fun and fast-moving video game that ... The cutting-edge game is designed to teach how the ... bacteria. The visual elements and simulations are critical for ...
... Health Organization, water scarcity affects four out of every ... and increased domestic and industrial water use are making ... global warming and pollution, a researcher at The University ... resources. , Western geography professor Katrina Moser studies the ...
Other Biology News:Fixing the education digital disconnect one video game at a time 2Fixing the education digital disconnect one video game at a time 3Researcher strives for watershed moment 2
Mol wt: average mol wt12,360.96 Da by calculation...
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
... The LIC Duet™ GST•Tag™ Ek Adaptor encodes ... ribosome binding site (rbs), ATG translation initation ... The GST•Tag sequence has been reported to ... the solubility of its fusion partners. The ...
A cost-effective serum for general cell growth requirements. All serum is collected from calves aged 10 days old or less....
Biology Products: